Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 146

Results For "ITU"

2067 News Found

Novartis commits US$ 250 million to the fight against NTDs and malaria
Public Health | June 24, 2022

Novartis commits US$ 250 million to the fight against NTDs and malaria

This includes USD 100 million to advance R&D of its neglected tropical disease program, focusing on novel drug candidates for four diseases.


Menarini Group and Radius Health submit new drug application to the USFDA for Elacestrant
Drug Approval | June 23, 2022

Menarini Group and Radius Health submit new drug application to the USFDA for Elacestrant

Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients


Avni announces subscription model menstrual hygiene products
Healthcare | June 23, 2022

Avni announces subscription model menstrual hygiene products

The array available for a subscription includes popular products to make menstrual hygiene a regular practice and extend further affordability to its users


Stelis Biopharma’s two biologics manufacturing facilities receive EU cGMP accreditation
News | June 18, 2022

Stelis Biopharma’s two biologics manufacturing facilities receive EU cGMP accreditation

Both manufacturing facilities are based out of Benguluru, India


Apollo Hospitals completes a procedure using new technology SENTINEL
Healthcare | June 16, 2022

Apollo Hospitals completes a procedure using new technology SENTINEL

Apollo Hospitals Chennai is the first healthcare institution in South India to use this protected TAVI / TAVR technology.


Stelis Biopharma's two biologics manufacturing facilities receive EU cGMP accreditation
Drug Approval | June 16, 2022

Stelis Biopharma's two biologics manufacturing facilities receive EU cGMP accreditation

Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation


LG Chem’s new drug for obesity receives additional orphan drug designation by US FDA
News | June 16, 2022

LG Chem’s new drug for obesity receives additional orphan drug designation by US FDA

With this designation, LG Chem will receive benefits such as exclusive sales rights in the US market for seven years, subsidies and tax cuts for clinical testing costs in the US, and preliminary consulting support related to development


80% of hypertensive women found to be obese: Study
Healthcare | June 16, 2022

80% of hypertensive women found to be obese: Study

48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs


CCI approves sale of biosimilars portfolio of Viatris to Biocon Biologics
News | June 15, 2022

CCI approves sale of biosimilars portfolio of Viatris to Biocon Biologics

The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics


Thermo Fisher Scientific launches new MS-based solutions
News | June 14, 2022

Thermo Fisher Scientific launches new MS-based solutions

Thermo Scientific Direct Mass Technology mode augments Thermo Scientific Q Exactive UHMR Hybrid Quadrupole-Orbitrap mass spectrometers with charge detection capabilities